2YPV image
Deposition Date 2012-11-01
Release Date 2013-02-20
Last Version Date 2024-10-23
Entry Detail
PDB ID:
2YPV
Keywords:
Title:
Crystal structure of the Meningococcal vaccine antigen factor H binding protein in complex with a bactericidal antibody
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:LIPOPROTEIN
Chain IDs:A
Chain Length:253
Number of Molecules:1
Biological Source:NEISSERIA MENINGITIDIS MC58
Polymer Type:polypeptide(L)
Molecule:FAB 12C1
Chain IDs:B (auth: H)
Chain Length:218
Number of Molecules:1
Biological Source:MUS MUSCULUS
Polymer Type:polypeptide(L)
Molecule:FAB 12C1
Chain IDs:C (auth: L)
Chain Length:214
Number of Molecules:1
Biological Source:MUS MUSCULUS
Ligand Molecules
Primary Citation
Defining a Protective Epitope on Factor H Binding Protein, a Key Meningococcal Virulence Factor and Vaccine Antigen.
Proc.Natl.Acad.Sci.USA 110 3304 ? (2013)
PMID: 23396847 DOI: 10.1073/PNAS.1222845110

Abstact

Mapping of epitopes recognized by functional monoclonal antibodies (mAbs) is essential for understanding the nature of immune responses and designing improved vaccines, therapeutics, and diagnostics. In recent years, identification of B-cell epitopes targeted by neutralizing antibodies has facilitated the design of peptide-based vaccines against highly variable pathogens like HIV, respiratory syncytial virus, and Helicobacter pylori; however, none of these products has yet progressed into clinical stages. Linear epitopes identified by conventional mapping techniques only partially reflect the immunogenic properties of the epitope in its natural conformation, thus limiting the success of this approach. To investigate antigen-antibody interactions and assess the potential of the most common epitope mapping techniques, we generated a series of mAbs against factor H binding protein (fHbp), a key virulence factor and vaccine antigen of Neisseria meningitidis. The interaction of fHbp with the bactericidal mAb 12C1 was studied by various epitope mapping methods. Although a 12-residue epitope in the C terminus of fHbp was identified by both Peptide Scanning and Phage Display Library screening, other approaches, such as hydrogen/deuterium exchange mass spectrometry (MS) and X-ray crystallography, showed that mAb 12C1 occupies an area of ∼1,000 Å(2) on fHbp, including >20 fHbp residues distributed on both N- and C-terminal domains. Collectively, these data show that linear epitope mapping techniques provide useful but incomplete descriptions of B-cell epitopes, indicating that increased efforts to fully characterize antigen-antibody interfaces are required to understand and design effective immunogens.

Legend

Protein

Chemical

Disease

Primary Citation of related structures